close

LATEST POSTS from Anne-Lise Berthier

Bacthera and Seres Therapeutics Collaborate for Commercial Manufacturing of SER-109, a Potential Treatment Against Recurrent C. difficile Infection

Bacthera and Seres Therapeutics Collaborate for Commercial Manufacturing of SER-109, a Potential Treatment Against Recurrent C. difficile Infection SER-109 has the potential to be the first-ever live biotherapeutic product (LBP) to be produced commercially; the collaboration with Seres Therapeutics is a critical milestone for Bacthera, a joint venture between a…..

GTP Bioways is acquiring IDBiotech and invests €12M in two GMP biopharmaceutical production units

GTP Bioways is acquiring IDBiotech and invests €12M in two GMP biopharmaceutical production units   Acquisition of CRO IDBiotech GTP Bioways, a French CDMO (Contract Development and Manufacturing Organization) specializing in the production of biotherapies and nanotherapies,  has acquired IDBiotech. Based in Issoire (France), this CRO  specialises in the development…..

Second phase II study for zilebesiran, an RNAi therapeutic for the treatment of hypertension

Second phase II study for zilebesiran, an RNAi therapeutic for the treatment of hypertension Alnylam Pharmaceuticals, a leading RNAi therapeutics company, has initiated KARDIA-2 (NCT05103332), a global Phase 2 study to evaluate the efficacy and safety of zilebesiran (formerly known as ALN-AGT), an investigational subcutaneous RNAi therapeutic targeting liver-expressed angiotensinogen…..

A new European initiative to accelerate the discovery and validation of biomarkers for neurodegenerative diseases

A new European initiative to accelerate the discovery and validation of biomarkers for neurodegenerative diseases Members of the European Platform for Neurodegenerative Diseases (EPND) will embark on a venture to establish a collaborative platform for efficient sample and data sharing, leveraging and linking existing European research infrastructures to accelerate the…..

New technology allows molecules to enter cells safely

  New technology allows molecules to enter cells safely Professor Braeckmans from Ghent University focused the last ten years on a method for safe engineering of therapeutic cells with photothermal nanofibers. Now, Nature Nanotechnology gives insight in how these biocompatible photothermal nanofibers were developed, and how, upon laser irradiation, cells…..

Intellia Therapeutics and SparingVision Announce Strategic Collaboration to Develop Novel Ocular Therapies Using CRISPR/Cas9 Technology

Intellia Therapeutics and SparingVision Announce Strategic Collaboration to Develop Novel Ocular Therapies Using CRISPR/Cas9 Technology Collaboration combines Intellia’s proprietary genome editing technology platform with SparingVision’s significant ophthalmology expertise Intellia will grant SparingVision exclusive rights to its leading in vivo CRISPR/Cas9 technology for the development of ocular therapies directed to three…..

Boehringer Ingelheim to expand veterinary vaccine capacity for emerging and transboundary diseases in France

Boehringer Ingelheim to expand veterinary vaccine capacity for emerging and transboundary diseases in France Boehringer Ingelheim announced an additional €100 million investment in its veterinary public health capabilities in Lyon-Jonage, France, to aid governments and public health organizations in managing future emerging and transboundary diseases. Transboundary and emerging diseases are…..